Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
67.13
+2.28 (3.52%)
May 9, 2025, 10:28 AM - Market open
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes | 211.73B | 206.62B | 198.11B | 192.75B | 182.45B | 173.47B | 161.15B | 154.71B | ||||||||||||||
Diabetes Growth | 16.05% | 19.11% | 22.93% | 24.59% | 23.92% | 24.31% | 21.21% | 23.23% | ||||||||||||||
Obesity | 72.54B | 65.15B | 54.97B | 48.42B | 44.83B | 41.63B | 35.89B | 27.97B | ||||||||||||||
Obesity Growth | 61.82% | 56.48% | 53.16% | 73.14% | 110.41% | 146.87% | 159.42% | 134.98% | ||||||||||||||
Rare Disease | 18.87B | 18.64B | 17.51B | 16.83B | 16.97B | 17.16B | 17.45B | 18.65B | ||||||||||||||
Rare Disease Growth | 11.21% | 8.60% | 0.34% | -9.75% | -14.09% | -16.45% | -14.49% | -5.81% |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes and Obesity Care | 134.75B | 127.72B | 117.71B | 110.96B | 106.68B | 99.62B | 90.58B | 82.01B | ||||||||||||||
Diabetes and Obesity Care Growth | 26.31% | 28.20% | 29.95% | 35.29% | 41.90% | 47.82% | 45.45% | 43.47% | ||||||||||||||
Rare Disease | 536.00M | 620.00M | 661.00M | 504.00M | 2.74B | 2.95B | 2.32B | 4.15B | ||||||||||||||
Rare Disease Growth | -80.40% | -78.99% | -71.50% | -87.86% | -50.18% | -60.20% | -74.47% | -55.13% |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 183.21B | 178.17B | 165.43B | 157.88B | 146.61B | 136.63B | 120.67B | 109.37B | ||||||||||||||||||
North America Growth | 24.96% | 30.41% | 37.09% | 44.35% | 46.01% | 49.97% | 42.69% | 40.05% | ||||||||||||||||||
International | 119.93B | 112.23B | 105.15B | 100.12B | 97.63B | 95.63B | 93.82B | 91.95B | ||||||||||||||||||
International Growth | 22.84% | 17.36% | 12.08% | 8.89% | 11.10% | 11.40% | 13.54% | 16.16% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.